DOI: 10.1055/s-00000059

Pneumologie

References

Castro M, Wenzel SE, Bleecker ER. et al.
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.

Lancet Respir Med 2014;
2: 879-890

Download Bibliographical Data

Access:
Access: